ArticleThe Lancet. Oncology2017

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.

Nico van Zandwijk et al.PubMed ↗Publisher ↗

No numbers read from the abstract.